Healthcare and Life Science
Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth
Optibrium, a leading developer of software and AI solutions for molecular design, today (8 July 2025) announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK businesses on high growth trajectories. ...
SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the publication of a peer-reviewed study in the International Wound Journal1. ...
Cognidox launches integrated Learning Management System to strengthen compliance and training for medical device and life science companies
Cognidox announced the launch of its new Learning Management System (LMS) — a powerful tool designed to help startups and scaling organisations meet training compliance requirements with greater efficiency, transparency, and control. ...
Bio-Rad expands Droplet Digital PCR offering through strategic acquisition and platform rollout
HERCULES, Calif. — July 7, 2025 — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announces the launch of four new Droplet Digital™ PCR (ddPCR™) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum™ ddPCR...
A £14.5 Billion Opening: How UK life sciences firms can lead China’s healthcare transformation
On 2 July 2025, China’s Ministry of Finance, National Health Commission, and National Disease Control Administration jointly announced a RMB 20.92 billion (£14.5 billion) Major Public Health Service Subsidy Fund for 2025. This signals a bold continuation of healthcare system modernisati...
A Chinese perspective on England’s “Fit for the Future” NHS plan
In July 2025, England launched its ambitious “Fit for the Future” strategy—a 10-year vision to transform the National Health Service (NHS). By shifting care closer to communities, accelerating digital transformation, and prioritising prevention, the plan addresses the urgent challenges ...
Groundbreaking science celebrated at prestigious technologies competition
Four winners share £100,000 prize pot to take the next steps to commercialising their technology. The winning scientists have developed exciting solutions to some of the biggest challenges we face today, in areas including antimicrobial resistance. ...
Milner Therapeutics Symposium showcases innovation in translational science
Hosted at West Road Concert Hall in Cambridge, the Symposium brings together leading minds from academia and industry to showcase cutting-edge research and its translation into novel therapeutics. ...
Healx and SCI Ventures join forces to uncover cures for paralysis with AI-driven drug discovery
Healx, a pioneer in AI-powered drug discovery for rare and neglected conditions, has partnered with SCI Ventures - the world’s first specialist venture fund focused on curing paralysis- to accelerate the discovery and development of therapies for spinal cord injury (SCI) using artifici...
Optibrium partners with TalTech on EU-Funded PhD Programme to advance sustainable drug discovery
The research will focus on developing faster and more accurate methods for predicting drug metabolism ...